MedPath

The effect of endurance and resistance training on diabetes

Not Applicable
Conditions
Type 2 diabetes.
Type 2 diabetes mellitus
Registration Number
IRCT20180721040542N1
Lead Sponsor
Shahrood University of Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
45
Inclusion Criteria

According to a physician's diagnosis, they have more than one year of type 2 Diabetes
Have a low mobility
Use only Glucose-lowering drugs (Metformin)

Exclusion Criteria

Have be Secondary complications of diabetes, such as ocular, kidney complications
Have be cardiovascular and inflammatory diseases
Have a physical injury

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fibroblast growth factor 21. Timepoint: Blood samples were taken at once in the first stage(pre-test) and secondly(post-test) after 8 weeks of exercise. Method of measurement: Fibroblast growth factor factor 21 kit.;Insulin resistance. Timepoint: Blood samples were taken once in the first stage(pre-test) and the second time(post-test) after 8 weeks of training. Method of measurement: Formula for evaluation of insulin resistance homeostasis model(HOMA-IR).
Secondary Outcome Measures
NameTimeMethod
Glucose. Timepoint: Blood samples were taken once in the first stage (pre-test) and the second time (post-test) after 8 weeks of training. Method of measurement: Glucose Kit and Colorimetric Enzymatic Method.;Insulin. Timepoint: Blood samples were taken once in the first stage (pre-test) and the second time (post-test) after 8 weeks of training. Method of measurement: Insulin kit and Elisa method.
© Copyright 2025. All Rights Reserved by MedPath